Tariffs/Trade

US Trade Representative will hold a September 22nd hearing on Section 301 investigation into Germany's pharmaceutical policies

StockNow breaking-news AI analysis

The US Trade Representative will conduct a September 22nd hearing regarding a Section 301 investigation into Germany's pharmaceutical policies.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more